NCT05996432View on ClinicalTrials.gov

Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 17, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

May 31, 2029

Conditions
Head and Neck Squamous Cell CarcinomaBrain Metastases
Interventions
PROCEDURE

Magnetic Resonance Imaging (MRI)

Participants will undergo Magnetic Resonance Imaging

PROCEDURE

Positron Emission Tomography (PET)

Participants will undergo Positron Emission Tomography

DRUG

18F-fluoromisonidazole

Given by IV

Trial Locations (1)

37203

RECRUITING

Vanderbilt University/Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Vanderbilt-Ingram Cancer Center

OTHER